Maitland, Kathryn https://orcid.org/0000-0002-0007-0645
Giallongo, Elisa
Hamaluba, Mainga
Alaroker, Florence
Opoka, Robert O.
Tagoola, Abner
Nalwanga, Damalie
Nabawanuka, Eva
Okiror, William
Nakuya, Margaret
Aromut, Denis
Williams, Thomas N.
Thomas, Karen
Harrison, David A.
Mouncey, Paul
Bush, Andrew
Fraser, J. F.
Rowan, Kathy
Olupot-Olupot, Peter
Kiguli, Sarah
,
Funding for this research was provided by:
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
Joint Global Health Trials (MR/L004364/1)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
European and Developing Countries Clinical Trials Partnership (RIA2016S-1636)
Article History
Received: 6 December 2024
Accepted: 2 June 2025
First Online: 1 July 2025
Declarations
:
: The School of Medicine Research Ethics Committee, Makerere University, Kampala, Uganda (protocol number #REC REF 2016–030, dated 29th February 2016), Kenya Medical Research Institute Scientific Ethics and Review Unit, Nairobi, Kenya (protocol number KEMRI/SERU/CGMR-C/0054/3330 dated 31st October 2016) and Imperial College Research Ethics Committee (protocol number 15IC3100 dated 12th January 2016) approved the trial.Written informed consent was obtained from parents or legal guardians prior to enrolment, or where previous written consent could not be obtained, verbal assent was accepted with delayed written informed consent as soon as practicable.
: Not applicable.
: The authors declare no competing interests.